Biolase, Inc. (BIOLQ) vs PROFUSA, Inc. (PFSA)
Biolase, Inc. and PROFUSA, Inc. are both Medical Devices companies. Biolase, Inc. is the larger, with a market value of $2.3M against $1.6M — 1.4× the size. Biolase, Inc. has negative trailing earnings, so its P/E is not meaningful; PROFUSA, Inc. trades at 0.0×. PROFUSA, Inc. has the higher net margin (0.00% vs −71.8%) and the higher return on invested capital (0.00% vs −109.5%). Across the 12 metrics below, Biolase, Inc. leads on 7 and PROFUSA, Inc. on 5.
Valuation
Profitability
| Metric | BIOLQ | PFSA | Medical Devices median |
|---|---|---|---|
| Gross margin | 34.44% | — | 56.01% |
| Operating margin | (29.37%) | 0.00% | (15.03%) |
| Net margin | (71.75%) | 0.00% | (20.40%) |
| Free cash flow margin | (28.55%) | 0.00% | (7.24%) |
| Return on equity | 1,349.30% | 173.14% | (15.32%) |
| Return on assets | (100.09%) | (2,860.47%) | (19.72%) |
| Return on invested capital | (109.48%) | 0.00% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack